|
Federal
Register Notices > Notices of
Registration - 2007
>
Cody Laboratories, Inc.
FR Doc E7-12948 [Federal Register: July 5, 2007 (Volume 72, Number 128)]
[Notices] [Page 36729] From the Federal Register Online via GPO Access [wais.access.gpo.gov]
[DOCID:fr05jy07-113]
DEPARTMENT OF JUSTICE
Drug Enforcement Administration
Manufacturer of Controlled Substances; Notice of Registration
By Notice dated April 18, 2006, and published in the Federal Register on
April 25, 2006, (71 FR 23948), Cody Laboratories, Inc., 601 Yellowstone Avenue,
Cody, Wyoming 82414, made application by letter to the Drug Enforcement
Administration (DEA) to be registered as a bulk manufacturer of the basic
classes of controlled substances listed in schedule II:
|
Drug
|
Schedule
|
|
Codeine (9050)
|
II
|
|
Dihydrocodeine (9120)
|
II
|
|
Methadone (9250)
|
II
|
|
Alfentanil (9737)
|
II
|
The company plans to manufacture in bulk, for distribution to its customers.
An objection and a request for a hearing were received by the DEA. In
accordance with 21 1301.33 bulk manufacturers applying for or registered in the
same basic class of narcotic or non-narcotic controlled substances may submit to
the DEA any comments on or objections to the issuance of a proposed application.
This regulation does not provide bulk manufacturers the right to request a
hearing on the proposed application. No hearing was scheduled to be heard on
this matter. DEA has reviewed the objection made against this pending
application and has determined that the registration of Cody Laboratories, Inc.
to manufacture the listed basic class of controlled substance is consistent with
the public interest at this time. DEA has investigated Cody Laboratories, Inc.
to ensure that the company's registration is consistent with the public
interest. The investigation has included inspection and testing of the company's
physical security systems, verification of the company's compliance with state
and local laws, and a review of the company's background and history. Therefore,
pursuant to 21
U.S.C. 823, and in accordance with 21 CFR
1301.33, the above
named company is granted registration as a bulk manufacturer of the basic class
of controlled substance listed.
Dated: June 26, 2007.
Joseph T. Rannazzisi,
Deputy Assistant Administrator, Office of Diversion Control, Drug
Enforcement Administration.
[FR Doc. E7-12948 Filed 7-3-07; 8:45 am]
BILLING CODE 4410-09-P
NOTICE: This is an
unofficial version. An official version of these publications may be obtained
directly from the Government Printing Office (GPO).
|